Macclesfield, United Kingdom

John S Morley

This inventor holds 4 USPTO granted patents. Top assignee: Imperial Chemical Industries Limited. Active years: 1978-1984.


% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Macclesfield, GB (1978 - 1982)
  • Cheadle Hulme, GB (1981 - 1984)

Company Filing History:


Years Active: 1978-1984

Loading Chart...
4 patents (USPTO):Explore Patents

Title: John S Morley: Innovator in Pharmaceutical Chemistry

Introduction

John S Morley is a distinguished inventor based in Macclesfield, GB. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 4 patents. His work primarily focuses on the development of novel compounds with therapeutic applications.

Latest Patents

Among his latest patents, Morley has developed dimers of peptide amides, which are compounds characterized by specific formulas involving alk-2-enyl radicals and various amino acids. These compounds serve as selective delta-opiate-receptor antagonists, which are crucial in pain management. Additionally, he has disclosed novel polypeptides that possess analgesic activity, along with processes for their manufacture and pharmaceutical compositions containing them.

Career Highlights

Morley is associated with Imperial Chemical Industries Limited, where he has been instrumental in advancing pharmaceutical research. His innovative approaches have led to the creation of compounds that are not only effective but also have the potential to improve patient outcomes in pain management.

Collaborations

Throughout his career, Morley has collaborated with notable colleagues, including Christopher F Hayward and Anand Swaroop Dutta. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking pharmaceutical solutions.

Conclusion

John S Morley is a prominent figure in the realm of pharmaceutical innovations, with a focus on developing compounds that address critical health issues. His contributions continue to shape the future of pain management therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…